Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+9.71%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$36.4B
AUM Growth
-$1.03B
(-2.8%)
Cap. Flow
-$3.65B
Cap. Flow
% of AUM
-10.03%
Top 10 Holdings %
Top 10 Hldgs %
13.87%
Holding
2,815
New
457
Increased
868
Reduced
1,197
Closed
289
Top Buys
| 1 |
Apple
AAPL
|
$510M |
| 2 |
Johnson & Johnson
JNJ
|
$406M |
| 3 |
Tesla
TSLA
|
$361M |
| 4 |
AT&T
T
|
$355M |
| 5 |
Roku
ROKU
|
$259M |
Top Sells
| 1 |
Home Depot
HD
|
$409M |
| 2 |
NVIDIA
NVDA
|
$341M |
| 3 |
Wells Fargo
WFC
|
$279M |
| 4 |
Netflix
NFLX
|
$249M |
| 5 |
Procter & Gamble
PG
|
$238M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Consumer Discretionary | 16.36% |
| 3 | Healthcare | 15.1% |
| 4 | Industrials | 8.5% |
| 5 | Communication Services | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
OGE Energy
OGE
$8.89B
| $9.98M | 0.03% |
308,500
-120,800
| -28% | -$3.91M |
|
577
Aldeyra Therapeutics
ALDX
$334M
| $9.93M | 0.03% |
835,400
+162,100
| +24% | +$1.93M |
|
578
Insperity
NSP
$2.03B
| $9.91M | 0.03% |
118,380
-80,300
| -40% | -$6.72M |
|
579
Universal Display
OLED
$6.91B
| $9.9M | 0.03% |
41,800
-1,800
| -4% | -$426K |
|
580
Ingevity
NGVT
$2.18B
| $9.89M | 0.03% |
131,000
-15,500
| -11% | -$1.17M |
|
581
Tenable Holdings
TENB
$3.76B
| $9.89M | 0.03% |
273,200
-12,400
| -4% | -$449K |
|
|
PVG
582
DELISTED
PRETIUM RESOURCES INC.
PVG
| $9.87M | 0.03% |
951,800
+297,400
| +45% | +$3.08M |
|
583
Funko
FNKO
$179M
| $9.78M | 0.03% |
496,800
+127,200
| +34% | +$2.5M |
|
584
EQT Corp
EQT
$32.2B
| $9.77M | 0.03% |
525,921
+338,921
| +181% | +$6.3M |
|
585
Builders FirstSource
BLDR
$16.5B
| $9.73M | 0.03% |
209,731
-66,769
| -24% | -$3.1M |
|
|
TGI
586
DELISTED
Triumph Group
TGI
| $9.61M | 0.03% |
522,900
+478,600
| +1,080% | +$8.8M |
|
587
Masimo
MASI
$8B
| $9.6M | 0.03% |
+41,800
| New | +$9.6M |
|
588
ManpowerGroup
MAN
$1.91B
| $9.59M | 0.03% |
97,000
+12,600
| +15% | +$1.25M |
|
589
Karyopharm Therapeutics
KPTI
$57.2M
| $9.58M | 0.03% |
60,680
+26,887
| +80% | +$4.24M |
|
590
The GEO Group
GEO
$2.92B
| $9.56M | 0.03% |
1,231,849
+968,800
| +368% | +$7.52M |
|
591
Metallus
MTUS
$713M
| $9.53M | 0.03% |
810,700
+624,200
| +335% | +$7.33M |
|
592
Mersana Therapeutics
MRSN
$34M
| $9.49M | 0.03% |
23,468
+3,872
| +20% | +$1.57M |
|
|
PRVB
593
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $9.45M | 0.03% |
900,400
+328,800
| +58% | +$3.45M |
|
594
Evolent Health
EVH
$1.11B
| $9.38M | 0.03% |
464,500
-55,300
| -11% | -$1.12M |
|
595
Pediatrix Medical
MD
$1.49B
| $9.37M | 0.03% |
368,000
-1,300
| -0.4% | -$33.1K |
|
596
Replimune Group
REPL
$494M
| $9.35M | 0.03% |
306,400
+85,600
| +39% | +$2.61M |
|
597
Federated Hermes
FHI
$4.1B
| $9.34M | 0.03% |
298,400
-137,900
| -32% | -$4.32M |
|
598
NOV
NOV
$4.95B
| $9.33M | 0.03% |
679,900
+230,900
| +51% | +$3.17M |
|
599
Immunovant
IMVT
$2.99B
| $9.31M | 0.03% |
580,500
+576,100
| +13,093% | +$9.24M |
|
600
Verra Mobility
VRRM
$3.97B
| $9.3M | 0.03% |
687,300
-58,200
| -8% | -$788K |
|